Arkolith/Insider Trading/TPST/Form 4

Whiting Samuel

Chief Medical OfficerTempest Therapeutics, Inc. (TPST) · full profile →Form 4 · filed Jul 3, 2024
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2024Buy(P)5K$2.13$10K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019279) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML